Gen House Overview
- Year Founded
-
2014
- Status
-
IPO Registration
- Employees
-
31
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
23
Gen House General Information
Description
Developer of original anti-tumor drugs designed for anti-cancer therapeutics. The company develops new tumor immunotherapy drugs and clinical detection methods based on precision medicine, enabling patients to have better treatment through the combined drug delivery of large molecules and small molecules.
Contact Information
Website
www.genhousebio.comCorporate Office
- Unit 401, Building 8, Area A, Phase III Biomedical Industrial Park
- Number 1 Xinze Road, Suzhou Industrial Park, Suzhou Area of China Pilot Free Trade Zone
- Suzhou, Jiangsu 215100
- China
Corporate Office
- Unit 401, Building 8, Area A, Phase III Biomedical Industrial Park
- Number 1 Xinze Road, Suzhou Industrial Park, Suzhou Area of China Pilot Free Trade Zone
- Suzhou, Jiangsu 215100
- China
Gen House Timeline
Gen House Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. IPO | 23-Jan-2026 | Announced | Generating Revenue | |||
| 11. Later Stage VC (Series BB) | 13-Jan-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B3) | 22-Oct-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B2) | 08-Jul-2024 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 08-Oct-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B1) | 21-Mar-2023 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 22-Aug-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 13-Feb-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 08-Jun-2021 | $29.7M | $34.6M | Completed | Generating Revenue | |
| 3. Later Stage VC | 25-Jul-2020 | $2.86M | $4.92M | Completed | Generating Revenue |
Gen House Patents
Gen House Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026153498-A1 | Amide compound, pharmaceutical composition comprising same, and use thereof | Pending | 17-Jan-2025 | ||
| WO-2025242126-A1 | Pharmaceutical composition and use thereof | Pending | 22-May-2024 | ||
| WO-2025201332-A1 | Oxadiazole compound, pharmaceutical composition comprising same, and use thereof | Pending | 26-Mar-2024 | ||
| AU-2024410908-A1 | Fused ring compound, pharmaceutical composition containing same and use thereof | Pending | 29-Dec-2023 | ||
| EP-4834908-A1 | Fused ring compound, pharmaceutical composition containing same and use thereof | Pending | 29-Dec-2023 | A61K31/519 |
Gen House Signals
Gen House Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BOHE Angel Fund | Venture Capital | Minority | ||
| Genova | Corporation | Minority | ||
| Guangzhou Industrial Investment Holding Group | Government | Minority | ||
| Vivatec | Corporation | Minority | ||
| YuanBio Venture Capital | Venture Capital | Minority |
Gen House FAQs
-
When was Gen House founded?
Gen House was founded in 2014.
-
Where is Gen House headquartered?
Gen House is headquartered in Suzhou, China.
-
What is the size of Gen House?
Gen House has 31 total employees.
-
What industry is Gen House in?
Gen House’s primary industry is Drug Discovery.
-
Is Gen House a private or public company?
Gen House is a Private company.
-
What is Gen House’s current revenue?
The current revenue for Gen House is .
-
How much funding has Gen House raised over time?
Gen House has raised $121M.
-
Who are Gen House’s investors?
BOHE Angel Fund, Genova, Guangzhou Industrial Investment Holding Group, Vivatec, and YuanBio Venture Capital are 5 of 23 investors who have invested in Gen House.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process